_id
691314a1ccc777a4e85d8012
Ticker
MDXXF
Name
Pharmala Biotech Holdings Inc
Exchange
OTCQB
Address
1055 West Georgia Street, Vancouver, BC, Canada, V6E 4N7
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://pharmala.ca
Description
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
Last Close
0.0751
Volume
-
Current Price
0.0878
Change
29.281249999999986
Last Updated
2026-01-05T10:19:18.614Z
Image
data:image/webp;base64,UklGRmgBAABXRUJQVlA4IFwBAAAQCwCdASpAAEAAPrFMnkmnJKKhMfcaSOAWCWoAzfA4e78er2x1cMBtl7uA3oYIUjdjRjTeoJyclvVSnVb7txWbTbERLt24ZmCcXfmV2shOtLJyNuQvm6+J90L7WeJagxYAAP76XgL2GeEdAZ4m3xhdvMNR5uAzdhpqN4L2L9TALdEreHdKGfZ3cvKMk44EhnW+RHAcFgXu0MNGD1WY6qth0E/KWWxcBqaxqKeYKT2mEEv6FJHNv5lIsPbLhT13H3IJocEUjzBd3pCMFiiQWPY/48kbVsun/s66Q0RNVkl5RuO1SozjZhk5Rt963vsgTiJ4jJBYZ/G6TPy/rhZTTs1ZFPIN58fQoggTxlLpTKyIbxun8IwNt4DWrDm2A6F/UP2DZ7/jm9+p/N8EY4TF/XDNmlVmEMygjfUbDNtIWFaPcoXEpw9u5FZIp9BNOhdWOtBG+K0NK/t9iCXLgAA=
Ipo Date
-
Market Cap
8177429
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.994
Sentiment Sources
1
Current Quarter
2025-11-30
Revenue
206440
Cost Of Revenue
34837
Gross Profit
171603
Operating Expenses
550088
Operating Income
-343648
Interest Expense
-
Pretax Income
-409695
Net Income
-409695
Eps
-0.0037718724896360855
Dividends Per Share
-
Shares Outstanding
108887215
Income Tax Expense
-
EBITDA
-
Operating Margin
-166.46386359232707
Total Other Income Expense Net
-66047
Cash
83523
Short Term Investments
773529
Receivables
193812
Inventories
357666
Total Current Assets
1645016
Property Plant Equipment
2603
Total Assets
3399171
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1027457
Equity
2371714
Bs_currency_symbol
CAD
Depreciation
29757
Change In Working Capital
114607
Cash From Operations
-116221
Capital Expenditures
10916
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
43336
Cf_currency_symbol
CAD
PE
-
PB
4.02101654204512
ROE
-17.27421603110662
ROA
-12.052791695386905
FCF
-127137
Fcf Percent
-0.615854485564813
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-11-30
Quarters > 0 > income Statement > revenue
206440
Quarters > 0 > income Statement > cost Of Revenue
34837
Quarters > 0 > income Statement > gross Profit
171603
Quarters > 0 > income Statement > operating Expenses
550088
Quarters > 0 > income Statement > operating Income
-343648
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-409695
Quarters > 0 > income Statement > net Income
-409695
Quarters > 0 > income Statement > eps
-0.0037718724896360855
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
108618465
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-166.46386359232707
Quarters > 0 > income Statement > total Other Income Expense Net
-66047
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
83523
Quarters > 0 > balance Sheet > short Term Investments
773529
Quarters > 0 > balance Sheet > receivables
193812
Quarters > 0 > balance Sheet > inventories
357666
Quarters > 0 > balance Sheet > total Current Assets
1645016
Quarters > 0 > balance Sheet > property Plant Equipment
2603
Quarters > 0 > balance Sheet > total Assets
3399171
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1027457
Quarters > 0 > balance Sheet > equity
2371714
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-409695
Quarters > 0 > cash Flow > depreciation
29757
Quarters > 0 > cash Flow > change In Working Capital
114607
Quarters > 0 > cash Flow > cash From Operations
-116221
Quarters > 0 > cash Flow > capital Expenditures
10916
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
43336
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.0037718724896360855
Quarters > 0 > ratios > PB
4.02101654204512
Quarters > 0 > ratios > ROE
-17.27421603110662
Quarters > 0 > ratios > ROA
-12.052791695386905
Quarters > 0 > ratios > FCF
-127137
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.615854485564813
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-08-31
Quarters > 1 > income Statement > revenue
267376
Quarters > 1 > income Statement > cost Of Revenue
34039
Quarters > 1 > income Statement > gross Profit
233337
Quarters > 1 > income Statement > operating Expenses
651593
Quarters > 1 > income Statement > operating Income
-384217
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-361134
Quarters > 1 > income Statement > net Income
-361134
Quarters > 1 > income Statement > eps
-0.0033875975492387287
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
106604753
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-143.69913530010172
Quarters > 1 > income Statement > total Other Income Expense Net
23083
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
40187
Quarters > 1 > balance Sheet > short Term Investments
920473
Quarters > 1 > balance Sheet > receivables
78133
Quarters > 1 > balance Sheet > inventories
369709
Quarters > 1 > balance Sheet > total Current Assets
1646864
Quarters > 1 > balance Sheet > property Plant Equipment
2918
Quarters > 1 > balance Sheet > total Assets
3419882
Quarters > 1 > balance Sheet > payables
366215
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
961732
Quarters > 1 > balance Sheet > equity
2458150
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-361134
Quarters > 1 > cash Flow > depreciation
29193
Quarters > 1 > cash Flow > change In Working Capital
-87981
Quarters > 1 > cash Flow > cash From Operations
-294939
Quarters > 1 > cash Flow > capital Expenditures
7117
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-3048
Quarters > 1 > cash Flow > net Change In Cash
-89674
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.0033875975492387287
Quarters > 1 > ratios > PB
3.8076998203527044
Quarters > 1 > ratios > ROE
-14.691292231963063
Quarters > 1 > ratios > ROA
-10.559838029499263
Quarters > 1 > ratios > FCF
-302056
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.12970498474059
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-05-31
Quarters > 2 > income Statement > revenue
135168
Quarters > 2 > income Statement > cost Of Revenue
9619
Quarters > 2 > income Statement > gross Profit
125549
Quarters > 2 > income Statement > operating Expenses
652133
Quarters > 2 > income Statement > operating Income
-516965
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-524235
Quarters > 2 > income Statement > net Income
-524235
Quarters > 2 > income Statement > eps
-0.004958987128002418
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
105714128
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-382.4610854640151
Quarters > 2 > income Statement > total Other Income Expense Net
-7270
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
129861
Quarters > 2 > balance Sheet > short Term Investments
1115430
Quarters > 2 > balance Sheet > receivables
115019
Quarters > 2 > balance Sheet > inventories
382427
Quarters > 2 > balance Sheet > total Current Assets
1836080
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
3631174
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
876154
Quarters > 2 > balance Sheet > equity
2755020
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-524235
Quarters > 2 > cash Flow > depreciation
29167
Quarters > 2 > cash Flow > change In Working Capital
40858
Quarters > 2 > cash Flow > cash From Operations
-257036
Quarters > 2 > cash Flow > capital Expenditures
7455
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-135541
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.004958987128002418
Quarters > 2 > ratios > PB
3.369013814200986
Quarters > 2 > ratios > ROE
-19.028355511030774
Quarters > 2 > ratios > ROA
-14.43706635925461
Quarters > 2 > ratios > FCF
-264491
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.9567575165719697
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2025-02-28
Quarters > 3 > income Statement > revenue
145657
Quarters > 3 > income Statement > cost Of Revenue
9504
Quarters > 3 > income Statement > gross Profit
136153
Quarters > 3 > income Statement > operating Expenses
939393
Quarters > 3 > income Statement > operating Income
-793736
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-810766
Quarters > 3 > income Statement > net Income
-810766
Quarters > 3 > income Statement > eps
-0.007754475956352865
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
104554583
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-544.9350185710265
Quarters > 3 > income Statement > total Other Income Expense Net
-17030
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
265403
Quarters > 3 > balance Sheet > short Term Investments
1244380
Quarters > 3 > balance Sheet > receivables
126830
Quarters > 3 > balance Sheet > inventories
344030
Quarters > 3 > balance Sheet > total Current Assets
2089072
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
3905878
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
812254
Quarters > 3 > balance Sheet > equity
3093624
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-810766
Quarters > 3 > cash Flow > depreciation
29120
Quarters > 3 > cash Flow > change In Working Capital
71343
Quarters > 3 > cash Flow > cash From Operations
-252833
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1560320
Quarters > 3 > cash Flow > net Change In Cash
66853
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.007754475956352865
Quarters > 3 > ratios > PB
2.967358795832978
Quarters > 3 > ratios > ROE
-26.207645143689085
Quarters > 3 > ratios > ROA
-20.757586386466755
Quarters > 3 > ratios > FCF
-252833
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.7358108432825061
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2025-08-31
Annuals > 0 > income Statement > revenue
605498
Annuals > 0 > income Statement > cost Of Revenue
53162
Annuals > 0 > income Statement > gross Profit
552336
Annuals > 0 > income Statement > operating Expenses
2743893
Annuals > 0 > income Statement > operating Income
-2138395
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-2175244
Annuals > 0 > income Statement > net Income
-2175244
Annuals > 0 > income Statement > eps
-0.020404756249470416
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
106604753
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-353.1630162279644
Annuals > 0 > income Statement > total Other Income Expense Net
-36849
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
40187
Annuals > 0 > balance Sheet > short Term Investments
920473
Annuals > 0 > balance Sheet > receivables
78133
Annuals > 0 > balance Sheet > inventories
369709
Annuals > 0 > balance Sheet > total Current Assets
1646864
Annuals > 0 > balance Sheet > property Plant Equipment
2918
Annuals > 0 > balance Sheet > total Assets
3419882
Annuals > 0 > balance Sheet > payables
366215
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
961732
Annuals > 0 > balance Sheet > equity
2458150
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-2175244
Annuals > 0 > cash Flow > depreciation
117047
Annuals > 0 > cash Flow > change In Working Capital
-27054
Annuals > 0 > cash Flow > cash From Operations
-1043697
Annuals > 0 > cash Flow > capital Expenditures
35267
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
1599772
Annuals > 0 > cash Flow > net Change In Cash
-379192
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.020404756249470416
Annuals > 0 > ratios > PB
3.2569277506661516
Annuals > 0 > ratios > ROE
-88.49110103126336
Annuals > 0 > ratios > ROA
-63.60582031777705
Annuals > 0 > ratios > FCF
-1078964
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.78194477933866
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2024-08-31
Annuals > 1 > income Statement > revenue
1035297
Annuals > 1 > income Statement > cost Of Revenue
147856
Annuals > 1 > income Statement > gross Profit
887441
Annuals > 1 > income Statement > operating Expenses
1678863
Annuals > 1 > income Statement > operating Income
-643566
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-823596
Annuals > 1 > income Statement > net Income
-823596
Annuals > 1 > income Statement > eps
-0.008584411208885671
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
95940884
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-62.16245193408268
Annuals > 1 > income Statement > total Other Income Expense Net
-180030
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
419379
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
200890
Annuals > 1 > balance Sheet > inventories
353534
Annuals > 1 > balance Sheet > total Current Assets
1043446
Annuals > 1 > balance Sheet > property Plant Equipment
401
Annuals > 1 > balance Sheet > total Assets
2898244
Annuals > 1 > balance Sheet > payables
358185
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
916884
Annuals > 1 > balance Sheet > equity
1981360
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-823596
Annuals > 1 > cash Flow > depreciation
70209
Annuals > 1 > cash Flow > change In Working Capital
-397327
Annuals > 1 > cash Flow > cash From Operations
-321360
Annuals > 1 > cash Flow > capital Expenditures
226419
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
772116
Annuals > 1 > cash Flow > net Change In Cash
224337
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.008584411208885671
Annuals > 1 > ratios > PB
3.6364721143053256
Annuals > 1 > ratios > ROE
-41.56720636330601
Annuals > 1 > ratios > ROA
-28.417069094251552
Annuals > 1 > ratios > FCF
-547779
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.5291032428375626
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2023-08-31
Annuals > 2 > income Statement > revenue
532003
Annuals > 2 > income Statement > cost Of Revenue
77904
Annuals > 2 > income Statement > gross Profit
454099
Annuals > 2 > income Statement > operating Expenses
1294953
Annuals > 2 > income Statement > operating Income
-762950
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-779813
Annuals > 2 > income Statement > net Income
-779813
Annuals > 2 > income Statement > eps
-0.009058897324512405
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
86082552
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-143.41084542756337
Annuals > 2 > income Statement > total Other Income Expense Net
-16863
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
195042
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
138804
Annuals > 2 > balance Sheet > inventories
122192
Annuals > 2 > balance Sheet > total Current Assets
713950
Annuals > 2 > balance Sheet > property Plant Equipment
2102
Annuals > 2 > balance Sheet > total Assets
2412538
Annuals > 2 > balance Sheet > payables
313982
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1029022
Annuals > 2 > balance Sheet > equity
1383516
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-779813
Annuals > 2 > cash Flow > depreciation
52765
Annuals > 2 > cash Flow > change In Working Capital
376862
Annuals > 2 > cash Flow > cash From Operations
-339656
Annuals > 2 > cash Flow > capital Expenditures
506735
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
189295
Annuals > 2 > cash Flow > net Change In Cash
-657096
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.009058897324512405
Annuals > 2 > ratios > PB
4.672732122505269
Annuals > 2 > ratios > ROE
-56.364581255294475
Annuals > 2 > ratios > ROA
-32.32334578771402
Annuals > 2 > ratios > FCF
-846391
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.5909515547844655
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2022-08-31
Annuals > 3 > income Statement > revenue
78070
Annuals > 3 > income Statement > cost Of Revenue
2288
Annuals > 3 > income Statement > gross Profit
75782
Annuals > 3 > income Statement > operating Expenses
1063653
Annuals > 3 > income Statement > operating Income
-985583
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-985583
Annuals > 3 > income Statement > net Income
-985583
Annuals > 3 > income Statement > eps
-0.011874694271951576
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
82998600
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-1262.4349942359422
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
852138
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
23216
Annuals > 3 > balance Sheet > inventories
116343
Annuals > 3 > balance Sheet > total Current Assets
1085474
Annuals > 3 > balance Sheet > property Plant Equipment
3799
Annuals > 3 > balance Sheet > total Assets
2330092
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
423783
Annuals > 3 > balance Sheet > equity
1906309
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-985583
Annuals > 3 > cash Flow > depreciation
12135
Annuals > 3 > cash Flow > change In Working Capital
111546
Annuals > 3 > cash Flow > cash From Operations
-625371
Annuals > 3 > cash Flow > capital Expenditures
994871
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
0
Annuals > 3 > cash Flow > net Change In Cash
-1620242
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.011874694271951576
Annuals > 3 > ratios > PB
3.269771511334207
Annuals > 3 > ratios > ROE
-51.701114562224696
Annuals > 3 > ratios > ROA
-42.29802943403093
Annuals > 3 > ratios > FCF
-1620242
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-20.75370821058025
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.0037718724896360855
Valuation > metrics > PB
4.02101654204512
Valuation > final Score
39.789834579548796
Valuation > verdict
34.0% Overvalued
Profitability > metrics > ROE
-17.27421603110662
Profitability > metrics > ROA
-24.905228885311754
Profitability > metrics > Net Margin
-1.9845717884130982
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4332128578740944
Risk > metrics > Interest Coverage
-5.203082653262071
Risk > final Score
39
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
41.92300179647296
Prev Valuations > 1
46.30986185799014
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-7
Prev Risks > 1
-224
Prev Risks > 2
-126
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:11:34.364Z
Earnings History > 0 > period
2025-11-30
Earnings History > 0 > report Date
2025-11-30
Earnings History > 0 > date
2025-11-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0027
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-08-31
Earnings History > 1 > report Date
2025-08-31
Earnings History > 1 > date
2025-08-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0025
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-05-31
Earnings History > 2 > report Date
2025-05-31
Earnings History > 2 > date
2025-05-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0035
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-02-28
Earnings History > 3 > report Date
2025-02-28
Earnings History > 3 > date
2025-02-28
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0056
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-11-30
Earnings History > 4 > report Date
2024-11-30
Earnings History > 4 > date
2024-11-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0039
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-08-31
Earnings History > 5 > report Date
2024-08-31
Earnings History > 5 > date
2024-08-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0018
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-05-31
Earnings History > 6 > report Date
2024-05-31
Earnings History > 6 > date
2024-05-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0034
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-31
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0034
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-02-29
Earnings History > 8 > report Date
2024-02-29
Earnings History > 8 > date
2024-02-29
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0019
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-02-29
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0019
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-11-30
Earnings History > 10 > report Date
2023-11-30
Earnings History > 10 > date
2023-11-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
0.0003
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-09-30
Earnings History > 11 > report Date
2023-11-30
Earnings History > 11 > date
2023-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
0.0003
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-08-31
Earnings History > 12 > report Date
2023-08-31
Earnings History > 12 > date
2023-08-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0007
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2023-06-30
Earnings History > 13 > report Date
2023-08-31
Earnings History > 13 > date
2023-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.0007
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2023-05-31
Earnings History > 14 > report Date
2023-05-31
Earnings History > 14 > date
2023-05-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.003
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2023-03-31
Earnings History > 15 > report Date
2023-05-31
Earnings History > 15 > date
2023-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.003
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-11-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Pharmala Biotech Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-11-30
EPS Actual
-0.0027
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-11-30)
(Last Updated 2025-11-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-11-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-11-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.